4.8 Article

Highly selective inhibition of histone demethylases by de novo macrocyclic peptides

Journal

NATURE COMMUNICATIONS
Volume 8, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ncomms14773

Keywords

-

Funding

  1. JSPS [21000005]
  2. Core Research for Evolutional Science and Technology (CREST) Program of Japan Science and Technology Agency (JST)
  3. BHF Centre of Research Excellence Oxford [RE/08/004]
  4. Engineering and Physical Sciences Research Council [EP/L003376/1]
  5. Cancer Research UK [C8717/A18245]
  6. European Union [298603]
  7. Wellcome Trust
  8. European Research Council [679479]
  9. St Edmund Hall Oxford
  10. Royal Society Dorothy Hodgkin Research Fellowship
  11. AbbVie
  12. Boehringer Ingelheim
  13. Canada Foundation for Innovation
  14. Canadian Institutes for Health Research
  15. Genome Canada
  16. GlaxoSmithKline
  17. Janssen
  18. Lilly Canada
  19. Novartis Research Foundation
  20. Ontario Ministry of Economic Development and Innovation
  21. Pfizer
  22. Takeda
  23. Wellcome Trust [092809/Z/10/Z]
  24. EPSRC [EP/L003376/1] Funding Source: UKRI
  25. Engineering and Physical Sciences Research Council [EP/L003376/1] Funding Source: researchfish
  26. Grants-in-Aid for Scientific Research [21000005] Funding Source: KAKEN
  27. European Research Council (ERC) [679479] Funding Source: European Research Council (ERC)

Ask authors/readers for more resources

The JmjC histone demethylases (KDMs) are linked to tumour cell proliferation and are current cancer targets; however, very few highly selective inhibitors for these are available. Here we report cyclic peptide inhibitors of the KDM4A-C with selectivity over other KDMs/2OG oxygenases, including closely related KDM4D/E isoforms. Crystal structures and biochemical analyses of one of the inhibitors (CP2) with KDM4A reveals that CP2 binds differently to, but competes with, histone substrates in the active site. Substitution of the active site binding arginine of CP2 to N-epsilon-trimethyl-lysine or methylated arginine results in cyclic peptide substrates, indicating that KDM4s may act on non-histone substrates. Targeted modifications to CP2 based on crystallographic and mass spectrometry analyses results in variants with greater proteolytic robustness. Peptide dosing in cells manifests KDM4A target stabilization. Although further development is required to optimize cellular activity, the results reveal the feasibility of highly selective non-metal chelating, substrate-competitive inhibitors of the JmjC KDMs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Biochemistry & Molecular Biology

The Chemical Probes Portal: an expert review-based public resource to empower chemical probe assessment, selection and use

Albert A. Antolin, Domenico Sanfelice, Alisa Crisp, Eloy Villasclaras Fernandez, Ioan L. Mica, Yi Chen, Ian Collins, Aled Edwards, Susanne Mueller, Bissan Al-Lazikani, Paul Workman

Summary: The Chemical Probes Portal is a public resource for researchers to select and use high-quality chemical probes. Chemical probes are crucial for protein function research and drug discovery, but the use of low-quality probes has led to erroneous conclusions. The portal provides background, principles, content, and technical development, and encourages researcher involvement.

NUCLEIC ACIDS RESEARCH (2023)

Article Biochemistry & Molecular Biology

Deep Annotation of Donated Chemical Probes (DCP) in Organotypic Human Liver Cultures and Patient-Derived Organoids from Tumor and Normal Colorectum

Claudia Tredup, Benardina Ndreshkjana, Natalie S. Schneider, Amelie Tjaden, Aurino M. Kemas, Sonia Youhanna, Volker M. Lauschke, Benedict-Tilman Berger, Andreas Kraemer, Lena M. Berger, Sandra Roehm, Stefan Knapp, Henner F. Farin, Susanne Mueller

Summary: Well-characterized small molecules are crucial for studying target proteins in biology and therapy. However, many compounds lack the necessary potency and selectivity for mechanistic cellular studies. The donated chemical probe (DCP) library provides an openly available collection of valuable and well-characterized tools, including a systematic description and comprehensive characterization data. It represents a unique resource for the biomedical research community.

ACS CHEMICAL BIOLOGY (2023)

Article Biochemistry & Molecular Biology

Oxazolo[5,4-f]quinoxaline-type selective inhibitors of glycogen synthase kinase-3α (GSK-3α): Development and impact on temozolomide treatment of glioblastoma cells

Mohamed Hasyeoui, Frederic Lassagne, William Erb, Manal Nael, Khaled M. Elokely, Apirat Chaikuad, Stefan Knapp, Adrian Jorda, Soraya L. Vall, Emie Quissac, Maite Verreault, Thomas Robert, Stephane Bach, Ali Samarat, Florence Mongin

Summary: The effects of FL-291 on the viability of neuroblastoma cells were investigated and found to have no significant impact on cell survival. Structural analysis revealed similar binding modes for FL-291 and CD-07 with GSK-3 beta. A library of analogs was designed and synthesized, and the new inhibitor MH-124 exhibited clear selectivity for GSK-3 alpha.

BIOORGANIC CHEMISTRY (2023)

Article Chemistry, Medicinal

Design, synthesis and characterisation of a novel type II B-RAF paradox breaker inhibitor

Rohit Arora, Joannes T. M. Linders, Samia Aci-Seche, Thomas Verheyen, Erika Van Heerde, Dirk Brehmer, Apirat Chaikuad, Stefan Knapp, Pascal Bonnet

Summary: The mutation V600E in B-Raf leads to mitogen activated protein kinase (MAPK) pathway activation, uncontrolled cell proliferation, and tumorigenesis. ATP competitive type I B-Raf inhibitors efficiently block the MAPK pathways in B-Raf mutant cells but induce conformational changes in the wild type B-Raf (wtB-Raf) kinase domain causing paradoxical hyperactivation. Type II inhibitors prevent heterodimerization by binding the kinase in the DFG-out conformation.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

Shifting the selectivity of pyrido[2,3-d]pyrimidin-7(8H)-one inhibitors towards the salt-inducible kinase (SIK) subfamily

Marcel Rak, Roberta Tesch, Lena M. Berger, Ekaterina Shevchenko, Monika Raab, Amelie Tjaden, Rezart Zhubi, Dimitrios-Ilias Balourdas, Andreas C. Joerger, Antti Poso, Andreas Kra, Lewis Elson, Aleksandar Luc, Thales Kronenberger, Thomas Hanke, Klaus Strebhardt, Mourad Sanhaji, Stefan Knapp

Summary: Salt-inducible kinases 1-3 (SIK1-3) are important regulators of cellular homeostasis. This study presents a structure-based approach to improve the selectivity of inhibitors targeting SIK kinases, resulting in the development of a valuable tool compound, MR22, which showed excellent selectivity and phenotypic effects in ovarian cancer cells.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

Discovery of potent Plasmodium falciparum protein kinase 6 (PfPK6) inhibitors with a type II inhibitor pharmacophore

Han Wee Ong, Anna Truong, Frank Kwarcinski, Chandi de Silva, Krisha Avalani, Tammy M. Havener, Michael Chirgwin, Kareem A. Galal, Caleb Willis, Andreas Kramer, Shubin Liu, Stefan Knapp, Emily R. Derbyshire, Reena Zutshi, David H. Drewry

Summary: Malaria is a global health problem with high morbidity and mortality rates. The emergence of drug resistance against current treatments emphasizes the need for alternative antimalarials. In this study, we discovered Ki8751 as an inhibitor of essential kinase PfPK6 and identified two compounds (67 and 79) with potent antiplasmodial activity against both blood and liver stages of malaria.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Translation initiation with exotic amino acids using EF-P-responsive artificial initiator tRNA

Takayuki Katoh, Hiroaki Suga

Summary: Using a chimeric initiator tRNA and EF-P can effectively suppress the N-terminal drop-off event induced by noncanonical initiator substrates, leading to the synthesis of full-length peptides. By optimizing translation conditions, complete suppression of exotic amino acids and up to a 1000-fold increase in expression level of full-length peptides can be achieved.

NUCLEIC ACIDS RESEARCH (2023)

Article Oncology

Mutation in the Common Docking Domain Affects MAP Kinase ERK2 Catalysis and Stability

Leonore Novak, Maria Petrosino, Alessandra Pasquo, Apirat Chaikuad, Roberta Chiaraluce, Stefan Knapp, Valerio Consalvi

Summary: ERK2 is a key player in the Ras-Raf-MEK-ERK signal transduction cascade and its variants in the common docking site have been found in cancer tissues. This study provides a comprehensive analysis of the structural, functional, and stability data of ERK2 wild-type and variants. Understanding the impact of single nucleotide variations on ERK2 can help design alternative therapies and move towards personalized medicine.

CANCERS (2023)

Article Chemistry, Multidisciplinary

Dynamical Nonequilibrium Molecular Dynamics Simulations Identify Allosteric Sites and Positions Associated with Drug Resistance in the SARS-CoV-2 Main Protease

H. T. Henry Chan, A. Sofia F. Oliveira, Christopher J. Schofield, Adrian J. Mulholland, Fernanda Duarte

Summary: The SARS-CoV-2 main protease (M-pro) is crucial in the coronavirus lifecycle by breaking down viral polyproteins. This study used dynamical nonequilibrium molecular dynamics (D-NEMD) simulations to examine the behavior of M-pro with and without substrates. The results reveal communication between M-pro subunits and identify networks associated with allosteric inhibition and nirmatrelvir resistance. These findings suggest that certain mutations can lead to drug resistance by altering the allosteric behavior of M-pro. Overall, the study demonstrates the usefulness of D-NEMD in identifying functionally relevant allosteric sites and networks, including those relevant to drug resistance.

JACS AU (2023)

News Item Biochemistry & Molecular Biology

Improving data quality in chemical biology

Stefan Knapp, Susanne Mueller

Summary: The quality and appropriate use of chemical tools play a crucial role in determining the quality and reliability of scientific data based on their utilization. Two papers now extend criteria to new modalities and critically review adherence to established guidelines.

NATURE CHEMICAL BIOLOGY (2023)

Article Biochemistry & Molecular Biology

Structural basis for binding of the renal carcinoma target hypoxia-inducible factor 2a to prolyl hydroxylase domain 2

William D. Figg Jr, Giorgia Fiorini, Rasheduzzaman Chowdhury, Yu Nakashima, Anthony Tumber, Michael A. McDonough, Christopher J. Schofield

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2023)

Article Cell Biology

5-Iodotubercidin sensitizes cells to RIPK1-dependent necroptosis by interfering with NF & kappa;B signaling

Chanchal Chauhan, Andreas Kraemer, Stefan Knapp, Mark Windheim, Alexey Kotlyarov, Manoj B. Menon, Matthias Gaestel

Summary: This study investigates the role of MAPK-activated protein kinase 2 (MK2) in cell death and identifies 5-Iodotubercidin (5-ITu) as a potent compound that sensitizes MK2-deficient cells to TNF-induced death. It is found that 5-ITu induces RIPK1-dependent necroptosis by suppressing IKK signaling in the absence of MK2 activity.

CELL DEATH DISCOVERY (2023)

Article Chemistry, Multidisciplinary

High-throughput screen with the L,D-transpeptidase LdtMt2 of Mycobacterium tuberculosis reveals novel classes of covalently reacting inhibitors

Mariska de Munnik, Pauline A. A. Lang, Francisco De Dios Anton, Monica Cacho, Robert H. Bates, Jurgen Brem, Beatriz Rodriguez Miquel, Christopher J. Schofield

Summary: Disrupting bacterial cell wall biosynthesis in Mycobacterium tuberculosis is a promising approach for treating tuberculosis. In this study, a high-throughput assay was used to identify potent inhibitors of L,D-transpeptidase Ldt(Mt2), which plays an essential role in the formation of cell wall peptidoglycan. These inhibitors were found to react covalently with the catalytic cysteine of Ldt(Mt2) and showed bactericidal effects on M. tuberculosis.

CHEMICAL SCIENCE (2023)

Article Biochemistry & Molecular Biology

Kinetic and inhibition studies on human Jumonji-C (JmjC) domain-containing protein 5

Anthony Tumber, Eidarus Salah, Lennart Brewitz, Thomas P. Corner, Christopher J. Schofield

Summary: Jumonji-C (JmjC) domain-containing protein 5 (JMJD5) is an oxygenase linked to circadian rhythm and cancer biology. Synthetic 2OG derivatives with cyclic carbon backbones are alternative cosubstrates of JMJD5, demonstrating structural similarity to factor inhibiting hypoxia-inducible transcription factor HIF-a (FIH). Broad-spectrum 2OG oxygenase inhibitors are also efficient JMJD5 inhibitors, while clinical inhibitors like roxadustat do not inhibit JMJD5. Solid phase extraction coupled to mass spectrometry assays will facilitate the development of selective JMJD5 inhibitors for cellular studies.

RSC CHEMICAL BIOLOGY (2023)

Article Biochemistry & Molecular Biology

Studies on the selectivity of the SARS-CoV-2 papain-like protease reveal the importance of the P2′ proline of the viral polyprotein

H. T. Henry Chan, Lennart Brewitz, Petra Lukacik, Claire Strain-Damerell, Martin A. Walsh, Christopher J. Schofield, Fernanda Duarte

Summary: This study investigates how SARS-CoV-2 PLpro binds viral polyprotein-derived oligopeptide substrates through molecular dynamics, docking, and quantum mechanics/molecular mechanics calculations. The results show that a proline located at the P2' position promotes catalysis.

RSC CHEMICAL BIOLOGY (2023)

No Data Available